Seite - 2 - in Cancer Nanotheranostics - What Have We Learnd So Far?

2 March 2016 | Cancer NanotheranosticsFrontiers in Chemistry After a quarter of century of rapid technological advances, research has revealed the complexity of cancer, a disease intimately related to the dynamic transformation of the genome. However, the full understanding of the molecular onset of this disease is still far from achieved and the search for mechanisms of treatment will follow closely. It is here that Nanotechnology enters the fray offering a wealth of tools to diagnose and treat cancer. In fact, the National Cancer Institute predicts that over the next years, nanotechnology will result in important advances in early detection, molecular imaging, targeted and multifunctional therapeutics, prevention and control of cancer. Nanotechnology offers numerous tools to diag- nose and treat cancer, such as new imaging agents, multifunctional devices capable of overcome CANCER NANOTHERANOSTICS: WHAT HAVE WE LEARNED SO FAR? The beauty of Nanotheranostics world. Image by João Conde created with Wordle (http://www.wordle.net). Topic Editors: João Conde, Massachusetts Institute of Technology and Harvard-MIT Division for Health Sciences and Technology, USA Pedro Viana Baptista, Universidade Nova de Lisboa, Portugal Jesús M. De La Fuente, Universidad de Zaragoza, Spain Furong Tian, Dublin Institute Technology, Ireland